Art

J-GLOBAL ID：201902201956980113   Reference number：19S1416137

Tolvaptan in patients with autosomal dominant polycystic kidney disease

Author (11)： Torres, Vicente E. (Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic) ,  Chapman, Arlene B. (Division of Nephrology, Emory University School of Medicine) ,  Devuyst, Olivier (Division of Nephrology, Cliniques Universitaires St. Luc, Université Catholique de Louvain Medical School) ,  Devuyst, Olivier (Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich) ,  Gansevoort, Ron T. (Department of Internal Medicine, University Medical Center Groningen, University of Groningen) ,  Grantham, Jared J. (Kidney Institute, Department of Internal Medicine, Kansas University Medical Center) ,  Higashihara, Eiji (Department of Urology, Kyorin University, School of Medicine) ,  Perrone, Ronald D. (Department of Medicine, Tufts Medical Center, Tufts University School of Medicine) ,  Krasa, Holly B. (Otsuka Pharmaceutical Development and Commercialization) ,  Ouyang, John (Otsuka Pharmaceutical Development and Commercialization) ,  Czerwiec, Frank S. (Otsuka Pharmaceutical Development and Commercialization)
Material： New England Journal of Medicine
Volume： 367  Issue： 25  Page： 2407-2418  Publication year： 2012 
JST Material Number： SCOPUS  ISSN： 0028-4793  CODEN： NEJMA 
Country of issue： United States (USA)  Language： English (EN)